Skip to main content
Diabetes, Metabolic Syndrome and Obesity logoLink to Diabetes, Metabolic Syndrome and Obesity
. 2020 Dec 16;13:5015. doi: 10.2147/DMSO.S295043

2-Dodecyl-6-Methoxycyclohexa-2,5-Diene-1,4-Dione Isolated from Averrhoa carambola L. Root Ameliorates Diabetic Nephropathy by Inhibiting the TLR4/MyD88/NF-κB Pathway [Corrigendum]

PMCID: PMC7756174  PMID: 33376370

Lu S, Zhang H, Wei X, et al. Diabetes Metab Syndr Obes. 2019;12:1355–1363.

The authors have advised Figure 7 on page 1360 is incorrect. Due to an error at the time of figure assembly NC and H in the TLR4-/-groups row were duplicated. The correct Figure 7 is shown below.

Figure 7.

Figure 7

Effect of DMDD on the ultrastructural changes in the renal tissue of WT and KO mice. NC: normal control, DN: diabetic nephropathy group, G: gliquidone group (10 mg.kg−1.d−1), H: high dosage of DMDD group (50 mg.kg−1.d−1), M: medium dosage of DMDD group (25 mg.kg−1.d−1), L: low dosage of DMDD group (12.5 mg.kg−1.d−1).

Abbreviations: DMDD, 2- dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione; WT, wild type; KO, knockout.

The authors apologize for this error and advise it does not affect the results of the paper.


Articles from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy are provided here courtesy of Dove Press

RESOURCES